[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.113.179. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
June 3, 1998

Drug Samples: Benefit or Bait?

Author Affiliations
 

Margaret A.WinkerMD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Senior EditorIndividualAuthor

JAMA. 1998;279(21):1698-1699. doi:10-1001/pubs.JAMA-ISSN-0098-7484-279-21-jbk0603

To the Editor.—The recent discussion1of drug samples and their use by physicians in their practices prompted me to share my observations. In partnership with the pharmaceutical industry, clinicians are given a largess of sample medications. Although the pharmaceutical industry spends an estimated $10 billion each year on drug promotion, little has been written about the (economic) impact on an individual practice.2,3

First Page Preview View Large
First page PDF preview
First page PDF preview
×